| Primary |
| Liver Transplant |
40.0% |
| Prophylaxis Against Renal Transplant Rejection |
33.3% |
| Renal Transplant |
13.3% |
| Crohn's Disease |
6.7% |
| Dermatitis Atopic |
6.7% |
|
| Multifocal Motor Neuropathy |
54.5% |
| Peripheral Sensorimotor Neuropathy |
18.2% |
| Diarrhoea |
9.1% |
| Pneumonia |
9.1% |
| Varicella |
9.1% |
|
| Secondary |
| Liver Transplant |
16.1% |
| Bone Marrow Transplant |
9.2% |
| Immunosuppressant Drug Therapy |
8.0% |
| Interstitial Lung Disease |
6.9% |
| Polymyositis |
6.9% |
| Drug Use For Unknown Indication |
5.7% |
| Lupus Nephritis |
5.7% |
| Insomnia |
4.6% |
| Panic Disorder |
4.6% |
| Premedication |
4.6% |
| Prophylaxis |
4.6% |
| Renal Transplant |
4.6% |
| Graft Versus Host Disease |
3.4% |
| Central Venous Catheterisation |
2.3% |
| Cytomegalovirus Infection |
2.3% |
| Epstein-barr Virus Infection |
2.3% |
| Gastritis Prophylaxis |
2.3% |
| Hyperlipidaemia |
2.3% |
| Transplant Rejection |
2.3% |
| Nephrogenic Anaemia |
1.1% |
|
| Renal Failure |
14.3% |
| Tremor |
8.0% |
| Portal Vein Thrombosis |
7.1% |
| Therapeutic Agent Toxicity |
7.1% |
| Sepsis |
6.3% |
| Thrombocytopenia |
6.3% |
| Bile Duct Stenosis |
5.4% |
| Tinnitus |
5.4% |
| Liver Transplant Rejection |
4.5% |
| Renal Impairment |
4.5% |
| Biliary Anastomosis Complication |
3.6% |
| Blood Creatinine Increased |
3.6% |
| Kidney Transplant Rejection |
3.6% |
| Somnolence |
3.6% |
| Urinary Tract Infection Enterococcal |
3.6% |
| Cytomegalovirus Infection |
2.7% |
| Hepatic Enzyme Increased |
2.7% |
| Nephropathy Toxic |
2.7% |
| Reperfusion Injury |
2.7% |
| Respiratory Failure |
2.7% |
|
| Concomitant |
| Renal Transplant |
23.0% |
| Drug Use For Unknown Indication |
19.7% |
| Acute Myeloid Leukaemia |
13.1% |
| Prophylaxis |
11.5% |
| Immunosuppression |
8.2% |
| Liver Transplant |
8.2% |
| Bone Marrow Transplant |
3.3% |
| Myasthenia Gravis |
3.3% |
| Arteriovenous Shunt Operation |
1.6% |
| Atrial Fibrillation |
1.6% |
| Bone Marrow Conditioning Regimen |
1.6% |
| Calcium Deficiency |
1.6% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Product Used For Unknown Indication |
1.6% |
|
| Death |
16.7% |
| Drug Toxicity |
12.5% |
| Intestinal Mucosal Hypertrophy |
12.5% |
| Sepsis |
8.3% |
| Biliary Dilatation |
4.2% |
| Brain Stem Haemorrhage |
4.2% |
| Graft Versus Host Disease |
4.2% |
| Hepatic Failure |
4.2% |
| Infection |
4.2% |
| Prothrombin Time Prolonged |
4.2% |
| Renal Failure |
4.2% |
| Skin Erosion |
4.2% |
| Staphylococcal Bacteraemia |
4.2% |
| Thrombotic Microangiopathy |
4.2% |
| Venoocclusive Liver Disease |
4.2% |
| Walking Aid User |
4.2% |
|
